Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02657434 |
Title | A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | Yes |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies |
Cisplatin + Pemetrexed Disodium Carboplatin + Pemetrexed Disodium |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | FRA | ESP | BEL | AUT |